How low can your cholesterol go? Updates on cholesterol management beyond statins

New Orleans, LA US
September 18, 2019

Cardiovascular disease remains a primary cause of death among adults in the United States. Morbidity and mortality associated with cardiovascular disease can be largely attributed to the development of atherosclerotic cardiovascular disease including coronary disease, myocardial infarction, ischemic stroke, and peripheral arterial disease. Management of LDL and cholesterol has been proven to reduce risk of developing cardiovascular disease. New guidelines have been released in November of 2018 from the ACC/AHA and other organizations updating their recommendations in these patients. New PCSK9 inhibitors are mentioned in the guidelines but more information has come out since the guidelines were released. This presentation will update audience on the most up to date information regarding cholesterol management.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives
  1. Identify updated recommendations made in the 2018 ACC/AHA guidelines on management of cholesterol
  2. Identify appropriate labs and monitoring for patients on pharmacological therapy for hyperlipidemia
  3. Discuss PCSK9 inhibitors and their place in therapy for the treatment of hyperlipidemia
Pharmacy technician learning objectives
  1. Describe the epidemiology and complications associated with hypercholesterolemia
  2. Identify brand/generic names of the pharmacological options for management of hyperlipidemia
  3.  Identify appropriate administration and dosage forms of pharmacological options for management of hyperlipidemia
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
Course expires: 
Event starts: 
09/18/2019 - 2:30pm CDT
Event ends: 
09/18/2019 - 3:30pm CDT
Ochsner Medical Center
1514 Jefferson Highway
New Orleans, LA 70121
United States
Relevant financial relationships: Planning committee members and speakers have nothing to disclose
The presenter will discuss off-label and investigative use of drugs
Planning committee members
Eric Coons, PharmD
Ochsner Medical Center
Kinsey Kowalski, PharmD
Ochsner Medical Center
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLA
Senior Clinical Manager
Elle Kline, PharmD
Pharmacy Resident
Ochsner Medical Center

Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-186-L04-P
Universal Activity Number: JA0006103-9999-19-186-L04-T
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU)

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance


Please login or register to take this course.